Hikal - Quaterly Results

09 Nov 2022 Evaluate
The Revenue for the quarter ended  September 2022 of Rs. 5587.50 millions grew by 19.12 % from Rs. 4690.60 millions.Net profit of the cmpany stood at Rs. 248.40 millions for the quarter ended September 2022 a decline of -43.61% from Rs. 440.50 millions  in the same quarter last year.Operating Profit reported a sharp decline to 709.80 millions from 917.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5587.50 4690.60 19.12 9375.40 9258.40 1.26 19427.20 17204.40 12.92
Other Income 12.50 8.70 43.68 45.20 40.50 11.60 48.90 49.80 -1.81
PBIDT 709.80 917.60 -22.65 969.20 1906.60 -49.17 3454.50 3278.70 5.36
Interest 108.00 79.60 35.68 220.90 159.50 38.50 312.10 362.00 -13.78
PBDT 601.80 838.00 -28.19 748.30 1747.10 -57.17 3142.40 2916.70 7.74
Depreciation 274.10 242.00 13.26 539.10 467.60 15.29 956.70 852.40 12.24
PBT 327.70 596.00 -45.02 209.20 1279.50 -83.65 2185.70 2064.30 5.88
TAX 79.30 155.50 -49.00 50.20 334.00 -84.97 580.60 732.80 -20.77
Deferred Tax 25.80 -4.70 -648.94 -3.30 -15.10 -78.15 -15.90 -62.70 -74.64
PAT 248.40 440.50 -43.61 159.00 945.50 -83.18 1605.10 1331.50 20.55
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 12.70 19.56 -35.06 10.34 20.59 -49.80 17.78 19.06 -6.69

Hikal Share Price

227.65 0.65 (0.29%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×